AbbVie

График котировок AbbVie


Добавить в список сравнения
Добавить в список отслеживания

Основные параметры

Цена ао 92.1
P/E 16.46
P/S 4.05
EV/EBITDA 14.59
Дивиденд ао 5.07
Див.доход ао 4.72
EBITDA 16.04

Технический анализ

Описание AbbVie

On October 19, 2011, Abbott Laboratories announced its plan to separate into two publicly traded companies. The «new» Abbott Laboratories would specialize in diversified products including medical devices, diagnostic equipment and nutrition products, while AbbVie would operate as a research-based pharmaceutical manufacturer